USTEKINUMAB-STBA

371 reported adverse events

Drug classes: Interleukin-12 Antagonist [EPC] Interleukin-23 Antagonist [EPC]

USTEKINUMAB-STBA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UROSTOMY 2 0.0168
1 SUSPECTED OFF LABEL USE 45 0.0100
2 HARVEY-BRADSHAW INDEX INCREASED 2 0.0067
3 LOSS OF THERAPEUTIC RESPONSE 8 0.0025
4 TREATMENT DELAYED 3 0.0017
5 SMALL INTESTINAL RESECTION 2 0.0017
6 WISDOM TEETH REMOVAL 2 0.0015
7 PALLIATIVE CARE 2 0.0013
8 AMYLASE INCREASED 4 0.0011
9 PRODUCT LEAKAGE 6 0.0011
See all enriched reactions for USTEKINUMAB-STBA